Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Clinical trial NCT03720470 · COMPLETED
Trial details
- NCT number
- NCT03720470
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-29
- Primary completion
- 2019-12-27
- Enrollment
- 838
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.